BPA Call 36C25523A0004-36C25523N0153

The Department of Veterans Affairs, Veterans Integrated Service Network 15, issued a BPA call to Advanced Accelerator Applications USA Inc. for PLUVICTO and LUTATHERA radiopharmaceutical products with a ceiling value of $1,140,421.68 on February 17, 2024, with ultimate completion on February 16, 2025. The call was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) on a firm fixed-price basis. Place of performance is New York, New York. PLUVICTO (lutetium Lu 177...

Veterans Integrated Service Network 15 issued a BPA call to Advanced Accelerator Applications USA Inc. for PLUVICTO and LUTATHERA with a ceiling value of $1.2 million, awarded February 17, 2026, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Performance takes place in Topeka, Kansas, with an ultimate completion date of February 16, 2027. The call is for supply of lutetium Lu 177–based radiopharmaceutical products used in targeted radioligand therapy for cancer treatment...

Veterans Integrated Service Network 9 issued a BPA call to Advanced Accelerator Applications USA Inc. valued at $2.9 million on December 20, 2025, expiring September 30, 2026, for radiopharmaceutical supply under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The call procures PLUVICTO (lutetium Lu 177 vipivotide tetraxetan) for cancer treatment, delivered to East Hanover, New Jersey. This call is issued under a $49.1 million single-award BPA with VISN 9 for PLUVICTO supply...

This federal contract award is for the delivery of the radiopharmaceutical products Lutetium Lu 177 LUTATHERA and PLUVICTO to the Veterans Integrated Service Network 10 (VISN 10) of the U.S. Department of Veterans Affairs (VA). The contract has a total ceiling value of $1,956,064.53 and an ultimate completion date of December 31, 2023. It was awarded on January 1, 2023 to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear...

Advanced Accelerator Applications USA Inc. was awarded a $194,773.86 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15. The firm fixed price order is for the delivery of LUTATHERA and PLUVICTO radiopharmaceuticals to the agency through December 31, 2022 to support patient care. No set-aside designation was applied to this contract, which will...

This federal contract award is for the delivery of PLUVICTO and LUTATHERA radiopharmaceuticals to the Department of Veterans Affairs (VA). The contract, valued at $486,934.65, was awarded to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of specialized nuclear medicine products. The contract was awarded under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is a Blanket Purchase Agreement (BPA) Call. This allows for the efficient...

Advanced Accelerator Applications USA Inc., a Novartis subsidiary specializing in radiopharmaceutical manufacturing, received a $166,145.70 firm fixed price Blanket Purchase Agreement (BPA) call for PLUVICTO (lutetium Lu 177 vipivotide tetraxetan) on March 28, 2025. This extension contract, which completes July 31, 2025, was awarded by Veterans Integrated Service Network 15 without a small business set-aside designation and will be performed in Millburn, New Jersey. PLUVICTO is an advanced...

Veterans Integrated Service Network 12 issued a $1.1 million firm fixed-price delivery order to Advanced Accelerator Applications USA Inc. on November 1, 2024, for PLUVICTO (lutetium Lu 177 vipivotide tetraxetan) radiopharmaceutical supply under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The order has a ceiling value of $1,095,121.02 and an ultimate completion date of October 31, 2025. Place of performance is Chicago, IL. Advanced Accelerator Applications USA Inc....

Advanced Accelerator Applications USA Inc., a Novartis subsidiary headquartered in Millburn, New Jersey, received a $132,796.51 firm fixed-price blanket purchase agreement call from Veterans Integrated Service Networks (VISN) 2 on October 1, 2024, for PLUVICTO (lutetium Lu 177 vipivotide tetraxetan). This award, which concludes September 30, 2025, was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) without small business set-aside designation. PLUVICTO is a...

This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Advanced Accelerator Applications USA Inc., a radiopharmaceutical company that specializes in targeted radioligand therapy and nuclear medicine. The contract is a delivery order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with a firm fixed price of $1,075,962.94 and a completion date of April 30, 2021. It was not set aside for any specific business type....